A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
Clinical trial NCT02102490 · COMPLETED
Trial details
- NCT number
- NCT02102490
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-10
- Primary completion
- 2016-04-30
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.